Pola-R-CHP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin and prednisone that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL) and post-transplant lymphoproliferative disorders.

**Synonyms:** - Cyclophosphamide/Doxorubicin/Polatuzumab Vedotin/Prednisone/Rituximab Regimen - Pola-R-CHP - Pola-R-CHP - Pola-R-CHP (rituximab-abbs) - Pola-R-CHP (rituximab-arrx) - Pola-R-CHP (rituximab-blit) - Pola-R-CHP (rituximab-pvvr) - Pola-R-CHP (rituximab-rite) - Pola-R-CHP (rituximab-rixa) - Pola-R-CHP (rituximab-rixi) - Polatuzumab Vedotin Plus Rituximab-Cyclophosphamide/Doxorubicin/Prednisone Regimen - Polatuzumab Vedotin Plus Rituximab-Cyclophosphamide/Hydroxydaunorubicin/Prednisone Regimen - Polatuzumab Vedotin Plus Rituximab/Cyclophosphamide/Doxorubicin/Prednisone Regimen - Polatuzumab Vedotin-piiq Plus Rituximab/Cyclophosphamide/Doxorubicin/Prednisone - Polivy Plus Rituxan Plus Cyclophosphamide/Doxorubicin/Prednisone Regimen